TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34677081

Group type: EXPERIMENTAL
Intervention: Fitbit and Facebook-based physical activity intervention
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fitbit only (control)
Number of subjects: 50
Study: 33317615

Group type: EXPERIMENTAL
Intervention: Web application (Naranj) for stress management
Number of subjects: 100

Group type: COMPARATOR
Intervention: App unrelated to stress management (Control)
Number of subjects: 100
Study: 34986013

Group type: EXPERIMENTAL
Intervention: Serious Games (SGs) played for 1 week during clinical practice
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no serious games)
Number of subjects: 60
Study: 33755884

Group type: EXPERIMENTAL
Intervention: Upadacitinib 6 mg BID
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Upadacitinib 6 mg BID or higher
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Upadacitinib (all dosages)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Upadacitinib 6 mg BID and 24 mg BID
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Upadacitinib 12 mg BID
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32171316

Group type: EXPERIMENTAL
Intervention: PAT‐A© intervention (individualised psychological treatment for anxiety)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Current Clinical Services Plus two emotional literacy skills sessions (control)
Number of subjects: 40
Study: 36037303

Group type: EXPERIMENTAL
Intervention: Metformin in combination with chemoradiation (chemoRT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (chemoRT alone)
Number of subjects: 10
Study: 34581678

Group type: EXPERIMENTAL
Intervention: Intervention infographic about the scientific process
Number of subjects: 1017

Group type: COMPARATOR
Intervention: Control infographic
Number of subjects: 1017
Study: 36271332

Group type: EXPERIMENTAL
Intervention: Palliative Care Needs Assessment (PCNA) arm
Number of subjects: 320

Group type: COMPARATOR
Intervention: Care-as-Usual arm
Number of subjects: 320
Study: 32759096

Group type: EXPERIMENTAL
Intervention: Polytetrafluoroethylene membrane valve (PTFEV)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Transannular pericardial patch (TAP)
Number of subjects: 30
Study: 35672074

Group type: EXPERIMENTAL
Intervention: NeuroBall plus usual care
Number of subjects: 24

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 24
Study: 32473596

Group type: EXPERIMENTAL
Intervention: Antithrombotic agents (especially heparin-based regimens)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immunomodulators with antithrombotic properties
Number of subjects: 0
Study: 33480123

Group type: EXPERIMENTAL
Intervention: Transmural Trauma Care Model (TTCM) implemented by a multidisciplinary team including trauma surgeon and hospital-based physical therapist, and a network of primary care trauma physical therapists
Number of subjects: 644

Group type: COMPARATOR
Intervention: Usual care provided in participating hospitals
Number of subjects: 644
Study: 35797775

Group type: EXPERIMENTAL
Intervention: Pathways Early Autism Intervention
Number of subjects: 56
Study: 34195468

Group type: EXPERIMENTAL
Intervention: 12 g soluble corn fiber (SCF)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: 600 mg calcium
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: 12 g SCF plus 600 mg calcium
Number of subjects: 243

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 243
Study: 34556552

Group type: EXPERIMENTAL
Intervention: Multi-component self-management intervention (data-logging nebulisers, digital platform, behavioural change sessions)
Number of subjects: 607

Group type: EXPERIMENTAL
Intervention: Multi-component self-management intervention
Number of subjects: 607

Group type: COMPARATOR
Intervention: Usual care (data-logging nebulisers)
Number of subjects: 607

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 607
Study: 35134993

Group type: EXPERIMENTAL
Intervention: Brief self-exercise education (brief-See)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Material-based education alone
Number of subjects: 46
Study: 33583866

Group type: EXPERIMENTAL
Intervention: Regular medical health check-ups for full-time employees
Number of subjects: 4652

Group type: COMPARATOR
Intervention: Regular medical health check-ups for part-time employees
Number of subjects: 4652

Group type: COMPARATOR
Intervention: Cost bearing for medical check-ups
Number of subjects: 4652

Group type: COMPARATOR
Intervention: Workplace size impact on medical check-ups for part-timers
Number of subjects: 4652
Study: 36461864

Group type: EXPERIMENTAL
Intervention: Synchronous learning using ETMCPR through Zoom
Number of subjects: 61

Group type: COMPARATOR
Intervention: Asynchronous learning using ETMCPR module on e-learning platform
Number of subjects: 61

Group type: COMPARATOR
Intervention: Asynchronous learning
Number of subjects: 61
Study: 33262113

Group type: EXPERIMENTAL
Intervention: Connected pre-habilitation program during neoadjuvant chemotherapy
Number of subjects: 136

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 136
Study: 35495881

Group type: EXPERIMENTAL
Intervention: Classical theory of Traditional Chinese Medicine (TCM)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Classical theory of TCM
Number of subjects: 100
Study: 35390756

Group type: EXPERIMENTAL
Intervention: Increase sleep condition (1.5 h/night increase)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Decrease sleep condition (1.5 h/night decrease)
Number of subjects: 37
Study: 34578993

Group type: EXPERIMENTAL
Intervention: Transgenic Camelina sativa oil (tCSO)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Fish oil (FO)
Number of subjects: 31
Study: 35551646

Group type: EXPERIMENTAL
Intervention: IOT-based management of NIPPV
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual NIPPV (control group)
Number of subjects: 200
Study: 33227569

Group type: EXPERIMENTAL
Intervention: Pyridoxine treatment
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 32928732

Group type: EXPERIMENTAL
Intervention: Ribavirin monotherapy
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 35974039

Group type: EXPERIMENTAL
Intervention: Taste recall training
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 42
Study: 34126996

Group type: EXPERIMENTAL
Intervention: Tart Cherry (TC) 500 mg
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 13
Study: 35910406

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided intercostal nerve block with 0.25% ropivacaine and 5 mg dexamethasone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Patient-controlled intravenous analgesia (PCIA) with fentanyl
Number of subjects: 60
Study: 35236727

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Usual care waitlist control
Number of subjects: 281
Study: 34593232

Group type: EXPERIMENTAL
Intervention: Tributyrin supplementation at 1 g/L
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Tributyrin supplementation at 2 g/L
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Tributyrin supplementation at 1 g/L and 2 g/L
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (pasteurized waste milk without supplementation)
Number of subjects: 48
Study: 35064588

Group type: EXPERIMENTAL
Intervention: Non-surgical mechanical debridement with photobiomodulation (test group)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Non-surgical mechanical debridement without photobiomodulation (control group)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Comparison between test and control groups
Number of subjects: 34
Study: 34943384

Group type: EXPERIMENTAL
Intervention: Uni-modal orofacial stimulation (OFS) over 10 consecutive days
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no OFS)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Uni-modal orofacial stimulation (OFS)
Number of subjects: 35
Study: 32492185

Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 1548
Study: 35409732

Group type: EXPERIMENTAL
Intervention: HRBT-based PARIs intervention program
Number of subjects: 1044

Group type: COMPARATOR
Intervention: Common health education program (control)
Number of subjects: 1044
Study: 32475085

Group type: EXPERIMENTAL
Intervention: Lower-fat diet (20% energy from fat)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Moderate-fat diet (35% energy from fat)
Number of subjects: 101
Study: 36167528

Group type: EXPERIMENTAL
Intervention: MERM device-observed self-administered therapy
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control (standard in-person directly observed therapy)
Number of subjects: 114
Study: 33160091

Group type: EXPERIMENTAL
Intervention: Positive psychology and motivational interviewing (PP-MI) intervention
Number of subjects: 45

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 45

Group type: COMPARATOR
Intervention: Motivational interviewing alone (MI-alone)
Number of subjects: 45
Study: 36240801

Group type: COMPARATOR
Intervention: 210 mg etrolizumab induction
Number of subjects: 385

Group type: COMPARATOR
Intervention: 105 mg etrolizumab maintenance
Number of subjects: 385

Group type: COMPARATOR
Intervention: 105 mg etrolizumab induction
Number of subjects: 385

Group type: COMPARATOR
Intervention: Placebo induction
Number of subjects: 385

Group type: COMPARATOR
Intervention: Etrolizumab maintenance
Number of subjects: 385

Group type: COMPARATOR
Intervention: Placebo maintenance
Number of subjects: 385
Study: 33637134

Group type: EXPERIMENTAL
Intervention: semi-standardized acupuncture plus routine care
Number of subjects: 110

Group type: COMPARATOR
Intervention: routine care alone
Number of subjects: 110
Study: 36514747

Group type: EXPERIMENTAL
Intervention: synbiotic + lactic acid bread (n=25)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: lactic acid bread (n=25)
Number of subjects: 100

Group type: COMPARATOR
Intervention: control bread (n=25)
Number of subjects: 100
Study: 34115399

Group type: EXPERIMENTAL
Intervention: TAU + ACT
Number of subjects: 35
Study: 34717532

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 μg kg‐ 1)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Lidocaine (1.5 mg kg‐ 1) with additional propofol (0.5 mg kg‐ 1)
Number of subjects: 106
Study: 33646594

Group type: EXPERIMENTAL
Intervention: Cephalomedial-to-lateral approach proctectomy (CEMP)
Number of subjects: 506

Group type: COMPARATOR
Intervention: Medial-to-lateral approach proctectomy (MAP)
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 506
Study: 32174775

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA) with propofol/remifentanil
Number of subjects: 128

Group type: COMPARATOR
Intervention: Volatile anesthetics (VA) with sevoflurane or desflurane/remifentanil
Number of subjects: 128
Study: 34281311

Group type: EXPERIMENTAL
Intervention: Concentrated growth factors (CGF) associated with implants
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard implant treatment (Control)
Number of subjects: 52
Study: 32871702

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35235632

Group type: EXPERIMENTAL
Intervention: Taper thread on straight-body implants with microthreads (group A)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Taper thread on straight-body implants without microthreads (group B)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Implants inserted with IT > 50 Ncm
Number of subjects: 142
Study: 32092617

Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane blocks (ESPB)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Paravertebral block (PVB)
Number of subjects: 66
Study: 36799922

Group type: EXPERIMENTAL
Intervention: Emergency cervical cerclage at 24–28 weeks gestation in addition to progesterone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34114717

Group type: EXPERIMENTAL
Intervention: Micro health insurance (MHI) offered through informal financial institutions (Self-Help Groups)
Number of subjects: 0
Study: 34128954

Group type: EXPERIMENTAL
Intervention: Pythagorean Self-Awareness Intervention (PSAI)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study: 33478173

Group type: EXPERIMENTAL
Intervention: African Circle Dance (ACD) intervention and psychoeducation
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control group (psychoeducation only)
Number of subjects: 198
Study: 32044851

Group type: EXPERIMENTAL
Intervention: Group A (2 specific cases)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Group B (2 specific cases)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Group AB (4 specific cases)
Number of subjects: 69
Study: 36107233

Group type: EXPERIMENTAL
Intervention: CON-ECC
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: ECC
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: CON
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control
Number of subjects: 42
Study: 35197344

Group type: EXPERIMENTAL
Intervention: Exercise and nutrition programme for 12 months
Number of subjects: 15

Group type: COMPARATOR
Intervention: Usual care (Control Group)
Number of subjects: 15
Study: 32245513

Group type: EXPERIMENTAL
Intervention: Combination of xenon and dexmedetomidine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Mono-anesthesia with sevoflurane
Number of subjects: 80
Study: 36082806

Group type: EXPERIMENTAL
Intervention: Fast-velocity concentric resistance training (FVCRT) for 10 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 34491227

Group type: EXPERIMENTAL
Intervention: PBO‐LLINs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LLIN plus IRS with alternative‐insecticide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PBO‐LLIN + IRS with alternative insecticide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PBO‐LLIN + LLML
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PBO‐LLIN + IRS + LLML
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PBO‐LLIN + LLML + IRS
Number of subjects: 0
Study: 35872982

Group type: EXPERIMENTAL
Intervention: Oral glucose tolerance test (OGTT)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Fasting glucagon levels
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: ELISA-derived fasting glucagon
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Glucagon 1-61, glicentin, and GLP-1 kinetics
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Plasma glucose concentrations
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: 2-hour post-challenge glucose
Number of subjects: 52
Study: 33906813

Group type: EXPERIMENTAL
Intervention: Decision aid brochure reviewed at initial consultation and two weeks post-consultation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard educational materials prior to initial consultation
Number of subjects: 20
Study: 32944404

Group type: EXPERIMENTAL
Intervention: Anlotinib
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study: 35839589

Group type: EXPERIMENTAL
Intervention: Online communication skills training (12 hours over 2 days) for the experimental group.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 60
Study: 34454941

Group type: EXPERIMENTAL
Intervention: Kangaroo Position (KP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 26
Study: 34965510

Group type: EXPERIMENTAL
Intervention: 4 mg of Dexamethasone (LoDex arm) with standardized physical activity for 4 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 8 mg of Dexamethasone (HiDex arm) with standardized physical activity for 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standardized physical activity (control group)
Number of subjects: 60
Study: 35171814

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) of the parahippocampal cortex (PHC)
Number of subjects: 6
Study: 34347707

Group type: EXPERIMENTAL
Intervention: CT radiomic model for predicting synchronous distant metastasis (SDM)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: CT radiomic signature
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Subgroup analysis of CT radiomic signature
Number of subjects: 172
Study: 34783907

Group type: EXPERIMENTAL
Intervention: Navigated patients
Number of subjects: 100

Group type: COMPARATOR
Intervention: Navigated network members
Number of subjects: 100
Study: 32196415

Group type: EXPERIMENTAL
Intervention: SPLCV infection in Ejumula (highly susceptible)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: SPLCV infection in Kakamega (moderately resistant)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: SPLCV infection (general observation)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Resistance to SPCSV and SPFMV
Number of subjects: 16
Study: 37966139

Group type: EXPERIMENTAL
Intervention: Mobile app intervention
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study: 33656569

Group type: EXPERIMENTAL
Intervention: siponimod
Number of subjects: 0

Group type: COMPARATOR
Intervention: beta interferons
Number of subjects: 0

Group type: COMPARATOR
Intervention: natalizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: oral cladribine
Number of subjects: 0

Group type: COMPARATOR
Intervention: ocrelizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: mitoxantrone
Number of subjects: 0
Study: 32942245

Group type: EXPERIMENTAL
Intervention: SHAE program in addition to conventional learning methods (e‐lectures, lab demonstration, and pair practice)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional learning methods only (waitlisted control group)
Number of subjects: 0
Study: 33601783

Group type: EXPERIMENTAL
Intervention: Different types of water storage containers (indoor/outdoor, natural/artificial, dark/light coloured, with/without lids) during dry (March-May 2015) and wet (October-December 2015) seasons
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Wet season
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Dry season
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Outdoor containers
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Light coloured and without lid containers during the dry season
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Indoor containers
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Light coloured containers in the dry season
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Container numbers
Number of subjects: 600
Study: 36063830

Group type: EXPERIMENTAL
Intervention: Olaparib plus abiraterone
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo plus abiraterone
Number of subjects: 142
Study: 33546451

Group type: EXPERIMENTAL
Intervention: Exercise plus dietary counselling
Number of subjects: 212

Group type: COMPARATOR
Intervention: Control
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 212
Study: 34795034

Group type: EXPERIMENTAL
Intervention: Tiotropium 18 μg via HandiHaler daily for 6 months
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 34903192

Group type: EXPERIMENTAL
Intervention: PROACTIVE psychosocial intervention
Number of subjects: 31
Study: 34789393

Group type: EXPERIMENTAL
Intervention: Simulation-based training
Number of subjects: 94

Group type: COMPARATOR
Intervention: Conventional operating room training
Number of subjects: 94
Study: 33755976

Group type: EXPERIMENTAL
Intervention: Hemoperfusion therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 60
Study: 34174097

Group type: EXPERIMENTAL
Intervention: Moderna vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33636147

Group type: EXPERIMENTAL
Intervention: Inactivated SARS-CoV-2 vaccine, BBV152
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 36413230

Group type: EXPERIMENTAL
Intervention: 8 mg/d of extended-release morphine
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 16 mg/d of extended-release morphine
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 24 mg/d of extended-release morphine
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 32 mg/d of extended-release morphine
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 32144641

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT) adapted for bipolar disorder
Number of subjects: 0
Study: 34782708

Group type: EXPERIMENTAL
Intervention: Atropine 0.02% (n=138)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Atropine 0.01% (n=142)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group (single-vision spectacles) (n=120)
Number of subjects: 400
Study: 34726114

Group type: EXPERIMENTAL
Intervention: GLN (0.3 g kg FFM-1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: PLA (non-calorific placebo)
Number of subjects: 10
Study: 34137904

Group type: EXPERIMENTAL
Intervention: 20 mg dextroamphetamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: 10 mg dextroamphetamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32102920

Group type: EXPERIMENTAL
Intervention: pCONUS HPC device with single antiplatelet therapy (SAPT) using acetylsalicylic acid (ASA)
Number of subjects: 15
Study: 36066025

Group type: COMPARATOR
Intervention: Conventional group (Con-G)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Isolation group (Iso-G)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Telemedicine-assisted airway model group (TAM-G)
Number of subjects: 89
Study: 32124531

Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy (TRT)
Number of subjects: 850

Group type: COMPARATOR
Intervention: Control group (no TRT)
Number of subjects: 850
Study: 35303938

Group type: EXPERIMENTAL
Intervention: Continuous renal replacement therapy (CRRT) and CytoSorb for 72 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: CRRT without CytoSorb
Number of subjects: 0

Group type: COMPARATOR
Intervention: Without both, CRRT and CytoSorb
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0